{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:41:05Z","timestamp":1793774465951,"version":"4.6.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The response to the coronavirus disease 2019 (COVID-19) pandemic has been hampered by lack of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antiviral therapy. Here we report the use of remdesivir in a patient with COVID-19 and the prototypic genetic antibody deficiency X-linked agammaglobulinaemia (XLA). Despite evidence of complement activation and a robust T cell response, the patient developed persistent SARS-CoV-2 pneumonitis, without progressing to multi-organ involvement. This unusual clinical course is consistent with a contribution of antibodies to both viral clearance and progression to severe disease. In the absence of these confounders, we take an experimental medicine approach to examine the in vivo utility of remdesivir. Over two independent courses of treatment, we observe a temporally correlated clinical and virological response, leading to clinical resolution and viral clearance, with no evidence of acquired drug resistance. We therefore provide evidence for the antiviral efficacy of remdesivir in vivo, and its potential benefit in selected patients.<\/jats:p>","DOI":"10.1038\/s41467-020-19761-2","type":"journal-article","created":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T06:13:36Z","timestamp":1607926416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":115,"title":["Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5646-4707","authenticated-orcid":false,"given":"Matthew S.","family":"Buckland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Galloway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caoimhe Nic","family":"Fhogartaigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Meredith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas M.","family":"Provine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Bloor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7774-7215","authenticated-orcid":false,"given":"Ane","family":"Ogbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wioleta M.","family":"Zelek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Smielewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Yakovleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffeney","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bergamaschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorinda","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2759-4027","authenticated-orcid":false,"given":"Frederica","family":"Mescia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9039-635X","authenticated-orcid":false,"given":"Erik J. M.","family":"Toonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl-Philipp","family":"Hackstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossain Delowar","family":"Akther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4901-0424","authenticated-orcid":false,"given":"Vinicius Adriano","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Ceron-Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimstan","family":"Periselneris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1299-4415","authenticated-orcid":false,"given":"Sorena","family":"Kiani-Alikhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Grigoriadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devan","family":"Vaghela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara E.","family":"Lear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Est\u00e9e","family":"T\u00f6r\u00f6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Stockton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Quick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya I.","family":"Coulter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Devlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"CITIID-NIHR COVID-19 BioResource Collaboration","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"MRC-Toxicology Unit COVID-19 Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth G. C.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7744-1790","authenticated-orcid":false,"given":"Willem H.","family":"Ouwehand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Estcourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heli","family":"Harvala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian B.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Screaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Loman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Doffinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7035-8997","authenticated-orcid":false,"given":"Paul A.","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Paul","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian G.","family":"Goodfellow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Klenerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9383-1054","authenticated-orcid":false,"given":"Paul J.","family":"Lehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3318-1851","authenticated-orcid":false,"given":"Nicholas J.","family":"Matheson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8616-074X","authenticated-orcid":false,"given":"James E. D.","family":"Thaventhiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,14]]},"reference":[{"key":"19761_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","volume":"30","author":"M Wang","year":"2020","unstructured":"Wang, M. et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 30, 269\u2013271 (2020).","journal-title":"Cell Res."},{"key":"19761_CR2","doi-asserted-by":"publisher","first-page":"6785","DOI":"10.1074\/jbc.RA120.013679","volume":"295","author":"CJ Gordon","year":"2020","unstructured":"Gordon, C. J. et al. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency. J. Biol. Chem. 295, 6785\u20136797 (2020).","journal-title":"J. Biol. Chem."},{"key":"19761_CR3","doi-asserted-by":"publisher","first-page":"104786","DOI":"10.1016\/j.antiviral.2020.104786","volume":"178","author":"KT Choy","year":"2020","unstructured":"Choy, K. T. et al. Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro. Antivir. Res. 178, 104786 (2020).","journal-title":"Antivir. Res."},{"key":"19761_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-020-2423-5","volume":"585","author":"BN Williamson","year":"2020","unstructured":"Williamson, B. N. et al. Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2. Nature 585, 273\u2013276 (2020).","journal-title":"Nature"},{"key":"19761_CR5","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","volume":"395","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet 395, 1569\u20131578 (2020).","journal-title":"Lancet"},{"key":"19761_CR6","doi-asserted-by":"crossref","unstructured":"Beigel, J. H. et al. Remdesivir for the treatment of Covid-19 - preliminary report. N. Engl. J. Med. 383, 992\u2013984 (2020).","DOI":"10.1056\/NEJMc2022236"},{"key":"19761_CR7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506 (2020).","journal-title":"Lancet"},{"key":"19761_CR8","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"17","author":"D Wang","year":"2020","unstructured":"Wang, D. et al. Clinical characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 17, 1061\u20131063 (2020).","journal-title":"JAMA"},{"key":"19761_CR9","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.jaip.2015.12.015","volume":"4","author":"D Bearden","year":"2016","unstructured":"Bearden, D., Collett, M., Quan, P. L., Costa-Carvalho, B. T. & Sullivan, K. E. Enteroviruses in X-linked agammaglobulinemia: update on epidemiology and therapy. J. Allergy Clin. Immunol. Pract. 4, 1059\u20131065 (2016).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"19761_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/(SICI)1096-9071(199711)53:3<273::AID-JMV16>3.0.CO;2-I","volume":"53","author":"JM Galama","year":"1997","unstructured":"Galama, J. M., Vogels, M. T., Jansen, G. H., Gielen, M. & Heessen, F. W. Antibodies against enteroviruses in intravenous Ig preparations: great variation in titres and poor correlation with the incidence of circulating serotypes. J. Med Virol. 53, 273\u2013276 (1997).","journal-title":"J. Med Virol."},{"key":"19761_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1100","volume":"1","author":"KH Huang","year":"2010","unstructured":"Huang, K. H. et al. B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection. Nat. Commun. 1, 102 (2010).","journal-title":"Nat. Commun."},{"key":"19761_CR12","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1182\/blood-2006-08-041525","volume":"109","author":"G Lake-Bakaar","year":"2007","unstructured":"Lake-Bakaar, G. et al. Hepatitis C virus and alanine aminotransferase kinetics following B-lymphocyte depletion with rituximab: evidence for a significant role of humoral immunity in the control of viremia in chronic HCV liver disease. Blood 109, 845\u2013846 (2007).","journal-title":"Blood"},{"key":"19761_CR13","doi-asserted-by":"publisher","first-page":"e1000080","DOI":"10.1371\/journal.pbio.1000080","volume":"7","author":"A Bergthaler","year":"2009","unstructured":"Bergthaler, A. et al. Impaired antibody response causes persistence of prototypic T cell-contained virus. PLoS Biol. 7, e1000080 (2009).","journal-title":"PLoS Biol."},{"key":"19761_CR14","doi-asserted-by":"publisher","first-page":"5896","DOI":"10.1128\/JVI.74.13.5896-5901.2000","volume":"74","author":"P Seiler","year":"2000","unstructured":"Seiler, P. et al. Additive effect of neutralizing antibody and antiviral drug treatment in preventing virus escape and persistence. J. Virol. 74, 5896\u20135901 (2000).","journal-title":"J. Virol."},{"key":"19761_CR15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/pai.13263","volume":"31","author":"A Soresina","year":"2020","unstructured":"Soresina, A. et al. Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover. Pediatr. Allergy Immunol. 31, 565\u2013569 (2020).","journal-title":"Pediatr. Allergy Immunol."},{"key":"19761_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jaci.2020.04.013","volume":"146","author":"I Quinti","year":"2020","unstructured":"Quinti, I. et al. A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia. J. Allergy Clin. Immunol. 146, 211\u2013213.e4 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"19761_CR17","first-page":"31320\u20138","volume":"S0091\u20136749","author":"I Meyts","year":"2020","unstructured":"Meyts, I. et al. Coronavirus Disease 2019 in patients with inborn errors of immunity: an international study. J. Allergy Clin. Immunol. S0091\u20136749, 31320\u20138 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"19761_CR18","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","volume":"181","author":"A Grifoni","year":"2020","unstructured":"Grifoni, A. et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181, 1489\u20131501.e15. (2020).","journal-title":"Cell"},{"key":"19761_CR19","doi-asserted-by":"publisher","first-page":"5490","DOI":"10.4049\/jimmunol.181.8.5490","volume":"181","author":"CK Li","year":"2008","unstructured":"Li, C. K. et al. T cell responses to whole SARS coronavirus in humans. J. Immunol. 181, 5490\u20135500 (2008).","journal-title":"J. Immunol."},{"key":"19761_CR20","doi-asserted-by":"publisher","first-page":"eaan5393","DOI":"10.1126\/sciimmunol.aan5393","volume":"2","author":"J Zhao","year":"2017","unstructured":"Zhao, J. et al. Recovery from the Middle East respiratory syndrome is associated with antibody and T-cell responses. Sci. Immunol. 2, eaan5393 (2017).","journal-title":"Sci. Immunol."},{"key":"19761_CR21","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1084\/jem.20070784","volume":"204","author":"JR Almeida","year":"2007","unstructured":"Almeida, J. R. et al. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J. Exp. Med. 204, 2473\u20132485 (2007).","journal-title":"J. Exp. Med."},{"key":"19761_CR22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"MZ Tay","year":"2020","unstructured":"Tay, M. Z., Poh, C. M., Renia, L., MacAry, P. A. & Ng, L. F. P. The trinity of COVID-19: immunity, inflammation and intervention. Nat. Rev. Immunol. 20, 363\u2013374 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"19761_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jmv.20499","volume":"78","author":"L Zhang","year":"2006","unstructured":"Zhang, L. et al. Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals. J. Med Virol. 78, 1\u20138 (2006).","journal-title":"J. Med Virol."},{"key":"19761_CR24","doi-asserted-by":"publisher","unstructured":"Zhao, J. et al. antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciaa344 (2020).","DOI":"10.1093\/cid\/ciaa344"},{"key":"19761_CR25","doi-asserted-by":"publisher","first-page":"e01753\u201318","DOI":"10.1128\/mBio.01753-18","volume":"9","author":"LE Gralinski","year":"2018","unstructured":"Gralinski, L. E. et al. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis. mBio 9, e01753\u201318 (2018).","journal-title":"mBio"},{"key":"19761_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2020.05.032","volume":"182","author":"B Shen","year":"2020","unstructured":"Shen, B. et al. Proteomic and metabolomic characterization of COVID-19 patient sera. Cell 182, 59\u201372.e15 (2020).","journal-title":"Cell"},{"key":"19761_CR27","doi-asserted-by":"crossref","unstructured":"Magro, C. et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl. Res. 220, 1\u201313 (2020).","DOI":"10.1016\/j.trsl.2020.04.007"},{"key":"19761_CR28","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","volume":"382","author":"J Grein","year":"2020","unstructured":"Grein, J. et al. Compassionate use of remdesivir for patients with severe Covid-19. N. Engl. J. Med. 382, 2327\u20132336 (2020).","journal-title":"N. Engl. J. Med."},{"key":"19761_CR29","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1016\/j.jaip.2020.06.046","volume":"8","author":"E Mira","year":"2020","unstructured":"Mira, E. et al. Rapid recovery of a SARS-CoV-2-infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma. J. Allergy Clin. Immunol. Pract. 8, 2793\u20132795 (2020).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"19761_CR30","first-page":"30945\u20134","volume":"S2213\u20132198","author":"H Jin","year":"2020","unstructured":"Jin, H. et al. Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma. J. Allergy Clin. Immunol. Pract. S2213\u20132198, 30945\u20134 (2020).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"19761_CR31","doi-asserted-by":"publisher","first-page":"23769","DOI":"10.1074\/jbc.M112.372425","volume":"287","author":"Y Bao","year":"2012","unstructured":"Bao, Y. et al. Tyrosine kinase Btk is required for NK cell activation. J. Biol. Chem. 287, 23769\u201323778 (2012).","journal-title":"J. Biol. Chem."},{"key":"19761_CR32","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1172\/JCI128322","volume":"130","author":"L Mao","year":"2020","unstructured":"Mao, L. et al. Bruton tyrosine kinase deficiency augments NLRP3 inflammasome activation and causes IL-1beta-mediated colitis. J. Clin. Invest 130, 1793\u20131807 (2020).","journal-title":"J. Clin. Invest"},{"key":"19761_CR33","doi-asserted-by":"publisher","first-page":"eabd0110","DOI":"10.1126\/sciimmunol.abd0110","volume":"5","author":"M Roschewski","year":"2020","unstructured":"Roschewski, M. et al. Inhibition of Bruton tyrosine kinase in patients with severe COVID-19. Sci. Immunol. 5, eabd0110 (2020).","journal-title":"Sci. Immunol."},{"key":"19761_CR34","doi-asserted-by":"publisher","first-page":"e0175961","DOI":"10.1371\/journal.pone.0175961","volume":"12","author":"FM Cavaliere","year":"2017","unstructured":"Cavaliere, F. M., Prezzo, A., Bilotta, C., Iacobini, M. & Quinti, I. The lack of BTK does not impair monocytes and polymorphonuclear cells functions in X-linked agammaglobulinemia under treatment with intravenous immunoglobulin replacement. PLoS ONE 12, e0175961 (2017).","journal-title":"PLoS ONE"},{"key":"19761_CR35","doi-asserted-by":"publisher","first-page":"e123158","DOI":"10.1172\/jci.insight.123158","volume":"4","author":"L Liu","year":"2019","unstructured":"Liu, L. et al. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight 4, e123158 (2019).","journal-title":"JCI Insight"},{"key":"19761_CR36","doi-asserted-by":"publisher","unstructured":"Harvala, H. et al. Convalescent plasma therapy for the treatment of patients with COVID-19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels. medRxiv https:\/\/doi.org\/10.1101\/2020.05.20.20091694 (2020).","DOI":"10.1101\/2020.05.20.20091694"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19761-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19761-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19761-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T21:03:59Z","timestamp":1670274239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-19761-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,14]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["19761"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-19761-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-79022\/v1","asserted-by":"object"}],"has-review":[{"id-type":"doi","id":"10.3410\/f.739224032.793581332","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,14]]},"assertion":[{"value":"27 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.J.M.T. is an employee of Hycult Biotechnology Ltd. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6385"}}